<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font17">for </span>
   <span class="font13">regulatory </span>
   <span class="font12">clinical </span>
   <span class="font12">that </span>
   <span class="font12">with </span>
   <span class="font12">The </span>
   <span class="font12">products </span>
   <span class="font12">{background </span>
   <span class="font11">(). </span>
   <span class="font11">European </span>
   <span class="font11">are </span>
   <span class="font11">complex </span>
   <span class="font11">margin </span>
   <span class="font11">medicinal </span>
   <span class="font11">from </span>
   <span class="font11">safety </span>
   <span class="font11">{border-style </span>
   <span class="font11">:â€". </span>
   <span class="font11">data </span>
   <span class="font11">iron </span>
   <span class="font11">NBCDs </span>
   <span class="font11">follow-on </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">guidance </span>
   <span class="font11">approval </span>
   <span class="font11">based </span>
   <span class="font11">need </span>
   <span class="font11">relevant </span>
   <span class="font11">Iron </span>
   <span class="font11">current </span>
   <span class="font11">their </span>
   <span class="font11">when </span>
   <span class="font10">adequate </span>
   <span class="font10">also </span>
   <span class="font10">different </span>
   <span class="font10">Article </span>
   <span class="font10">Available </span>
   <span class="font10">Medicines </span>
   <span class="font10">NBCD </span>
   <span class="font10">This </span>
   <span class="font10">product </span>
   <span class="font10">use </span>
   <span class="font10">.collab: </span>
   <span class="font10">Drug </span>
   <span class="font10">application </span>
   <span class="font10">at: </span>
   <span class="font10">efficacy </span>
   <span class="font10">issues </span>
   <span class="font10">looking </span>
   <span class="font10">not </span>
   <span class="font10">online </span>
   <span class="font10">similar </span>
   <span class="font10">were </span>
   <span class="font10">within </span>
   <span class="font10">FDA </span>
   <span class="font10">drugs </span>
   <span class="font10">into </span>
   <span class="font10">manufacturing </span>
   <span class="font10">marketing </span>
   <span class="font10">specific </span>
   <span class="font10">therapeutic </span>
   <span class="font10">was </span>
   <span class="font10">Agency </span>
   <span class="font10">approved </span>
   <span class="font10">can </span>
   <span class="font10">drug </span>
   <span class="font10">have </span>
   <span class="font10">interchangeability </span>
   <span class="font10">oxide </span>
   <span class="font10">products. </span>
   <span class="font10">scientific </span>
   <span class="font10">through </span>
   <span class="font10">under </span>
   <span class="font10">which </span>
   <span class="font10">Complex </span>
   <span class="font10">between </span>
   <span class="font10">case </span>
   <span class="font10">deficiency </span>
   <span class="font10">formulations </span>
   <span class="font10">group </span>
   <span class="font10">its </span>
   <span class="font10">major </span>
   <span class="font10">preclinical </span>
   <span class="font10">quality </span>
   <span class="font10">related </span>
   <span class="font10">submitted </span>
   <span class="font10">these </span>
   <span class="font10">this </span>
   <span class="font10">any </span>
   <span class="font10">attributes </span>
   <span class="font10">cannot </span>
   <span class="font10">could </span>
   <span class="font10">discussion </span>
   <span class="font10">equivalence </span>
   <span class="font10">fact, </span>
   <span class="font10">impact </span>
   <span class="font10">physicochemical </span>
   <span class="font10">procedure </span>
   <span class="font10">px; </span>
   <span class="font10">requirements </span>
   <span class="font10">should </span>
   <span class="font10">{font-family </span>
   <span class="font10">(), </span>
   <span class="font10">(i) </span>
   <span class="font10">(ii) </span>
   <span class="font10">after </span>
   <span class="font10">been </span>
   <span class="font10">critical </span>
   <span class="font10">decisions </span>
   <span class="font10">established </span>
   <span class="font10">font-size </span>
   <span class="font10">generic </span>
   <span class="font10">has </span>
   <span class="font10">most </span>
   <span class="font10">non-biological </span>
   <span class="font10">product. </span>
   <span class="font10">would </span>
   <span class="font10">Drugs </span>
   <span class="font10">NBCDs, </span>
   <span class="font10">active </span>
   <span class="font10">analytical </span>
   <span class="font10">better </span>
   <span class="font10">biological </span>
   <span class="font10">categories </span>
   <span class="font10">comparative </span>
   <span class="font10">double; </span>
   <span class="font10">evidence </span>
   <span class="font10">hybrid </span>
   <span class="font10">nanoparticles, </span>
   <span class="font10">path </span>
   <span class="font10">pharmaceutical </span>
   <span class="font10">procedures </span>
   <span class="font10">process </span>
   <span class="font10">products, </span>
   <span class="font10">properties </span>
   <span class="font10">risk </span>
   <span class="font10">same </span>
   <span class="font10">there </span>
   <span class="font10">using </span>
   <span class="font10">will </span>
   <span class="font10">(NBCDs) </span>
   <span class="font10">(iii) </span>
   <span class="font10">EMA </span>
   <span class="font10">Food </span>
   <span class="font10">Non-Biological </span>
   <span class="font10">Regulatory </span>
   <span class="font10">Sci. </span>
   <span class="font10">additional </span>
   <span class="font10">al.. </span>
   <span class="font10">all </span>
   <span class="font10">appropriate </span>
   <span class="font10">authors </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">carbohydrate </span>
   <span class="font10">challenges </span>
   <span class="font10">clinically </span>
   <span class="font10">comparability </span>
   <span class="font10">consider </span>
   <span class="font10">efficacy, </span>
   <span class="font10">efficacy. </span>
   <span class="font10">evaluation </span>
   <span class="font10">expert </span>
   <span class="font10">final </span>
   <span class="font10">how </span>
   <span class="font10">include </span>
   <span class="font10">including </span>
   <span class="font10">innovator </span>
   <span class="font10">level </span>
   <span class="font10">main </span>
   <span class="font10">more </span>
   <span class="font10">needs </span>
   <span class="font10">other </span>
   <span class="font10">performance </span>
   <span class="font10">potential </span>
   <span class="font10">previously </span>
   <span class="font10">product, </span>
   <span class="font10">set </span>
   <span class="font10">solid; </span>
   <span class="font10">sucrose </span>
   <span class="font10">that, </span>
   <span class="font10">vivo </span>
   <span class="font10">weight </span>
   <span class="font10">without </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(); </span>
   <span class="font10">(i.e., </span>
   <span class="font10">AAPS </span>
   <span class="font10">Administration </span>
   <span class="font10">Center </span>
   <span class="font10">Clinical </span>
   <span class="font10">Europe </span>
   <span class="font10">Evaluation </span>
   <span class="font10">FarmÃ¡cia, </span>
   <span class="font10">Guidance </span>
   <span class="font10">LisboaLisboaPortugal[], </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">Prevention </span>
   <span class="font10">Product </span>
   <span class="font10">Research </span>
   <span class="font10">Universidade </span>
   <span class="font10">University </span>
   <span class="font10">acetate </span>
   <span class="font10">addressed </span>
   <span class="font10">and/or </span>
   <span class="font10">applications </span>
   <span class="font10">appraisal </span>
   <span class="font10">approach </span>
   <span class="font10">article </span>
   <span class="font10">assessment </span>
   <span class="font10">biosimilars </span>
   <span class="font10">bold </span>
   <span class="font10">cancer </span>
   <span class="font10">cases, </span>
   <span class="font10">characterization </span>
   <span class="font10">characterized </span>
   <span class="font10">complexity </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">criteria </span>
   <span class="font10">data. </span>
   <span class="font10">decision </span>
   <span class="font10">delivery </span>
   <span class="font10">design </span>
   <span class="font10">development </span>
   <span class="font10">dextran </span>
   <span class="font10">differences </span>
   <span class="font10">dissolution </span>
   <span class="font10">distribution </span>
   <span class="font10">diversity </span>
   <span class="font10">documents </span>
   <span class="font10">em; </span>
   <span class="font10">first </span>
   <span class="font10">follow </span>
   <span class="font10">framework </span>
   <span class="font10">fully </span>
   <span class="font10">further </span>
   <span class="font10">general </span>
   <span class="font10">innovators </span>
   <span class="font10">legal </span>
   <span class="font10">material </span>
   <span class="font10">might </span>
   <span class="font10">molecular </span>
   <span class="font10">nanocrystals </span>
   <span class="font10">nanoparticles </span>
   <span class="font10">new </span>
   <span class="font10">number </span>
   <span class="font10">original </span>
   <span class="font10">originator </span>
   <span class="font10">pathway </span>
   <span class="font10">pertaining </span>
   <span class="font10">polymeric </span>
   <span class="font10">previous </span>
   <span class="font10">products: </span>
   <span class="font10">pt;} </span>
   <span class="font10">risks </span>
   <span class="font10">similarity </span>
   <span class="font10">size </span>
   <span class="font10">such </span>
   <span class="font10">two </span>
   <span class="font10">uncertainty </span>
   <span class="font10">work </span>
   <span class="font10">â€¢ </span>
   <span class="font10">â€œfollow-onâ€� </span>
   <span class="font10">â€œsimilarâ€� </span>
  </p>
 </body>
</html>
